Shandong Historical Income Statement

301206 Stock   28.12  0.09  0.32%   
Historical analysis of Shandong Sanyuan income statement accounts such as Net Interest Income of 5.6 M, Interest Income of 6.2 M or Selling General Administrative of 9.7 M can show how well Shandong Sanyuan Biotechnology performed in making a profits. Evaluating Shandong Sanyuan income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shandong Sanyuan's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Shandong Sanyuan Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shandong Sanyuan Bio is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Sanyuan Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Shandong Income Statement Analysis

Shandong Sanyuan Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shandong Sanyuan shareholders. The income statement also shows Shandong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Shandong Sanyuan Income Statement Chart

At present, Shandong Sanyuan's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6.2 M, whereas Tax Provision is forecasted to decline to about 2.7 M.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Shandong Sanyuan Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Shandong Sanyuan Biotechnology minus its cost of goods sold. It is profit before Shandong Sanyuan operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Shandong Sanyuan's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shandong Sanyuan Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Sanyuan Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, Shandong Sanyuan's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6.2 M, whereas Tax Provision is forecasted to decline to about 2.7 M.
 2021 2022 2023 2024 (projected)
Net Interest Income2.8M13.6M5.2M5.6M
Tax Provision84.5M20.3M2.8M2.7M

Shandong Sanyuan income statement Correlations

-0.2-0.220.310.880.980.970.990.370.730.590.58-0.180.990.990.44
-0.20.990.690.09-0.38-0.4-0.10.370.080.410.40.65-0.11-0.1-0.8
-0.220.990.650.04-0.4-0.41-0.120.30.030.350.340.58-0.14-0.12-0.76
0.310.690.650.680.140.090.430.770.730.890.880.610.410.43-0.64
0.880.090.040.680.790.750.930.750.960.90.90.240.920.93-0.01
0.98-0.38-0.40.140.791.00.950.240.640.450.44-0.330.950.950.6
0.97-0.4-0.410.090.751.00.930.170.580.390.38-0.390.940.930.64
0.99-0.1-0.120.430.930.950.930.490.80.690.68-0.051.01.00.32
0.370.370.30.770.750.240.170.490.850.930.940.80.470.49-0.59
0.730.080.030.730.960.640.580.80.850.940.940.370.790.8-0.17
0.590.410.350.890.90.450.390.690.930.941.00.60.680.69-0.44
0.580.40.340.880.90.440.380.680.940.941.00.610.670.68-0.45
-0.180.650.580.610.24-0.33-0.39-0.050.80.370.60.61-0.07-0.05-0.89
0.99-0.11-0.140.410.920.950.941.00.470.790.680.67-0.071.00.33
0.99-0.1-0.120.430.930.950.931.00.490.80.690.68-0.051.00.32
0.44-0.8-0.76-0.64-0.010.60.640.32-0.59-0.17-0.44-0.45-0.890.330.32
Click cells to compare fundamentals

Shandong Sanyuan Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shandong Stock

Shandong Sanyuan Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shandong Sanyuan shareholders. The income statement also shows Shandong investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).